Compared to that in the corresponding normal tissues, PKM2 showed higher expression in colorectal cancer, lung adenocarcinoma, ovarian cancer, clear cell RCC, and UCEC (Figure 1(b)). Here, PKM is linked to ovarian carcinoma.